Affordable Access

deepdyve-link
Publisher Website

The natural history of clinically complete responders to neoadjuvant chemotherapy for urothelial carcinoma of the bladder.

Authors
  • Meyer, Alexa1
  • Ghandour, Rashed2
  • Bergman, Ari2
  • Castaneda, Crystal2
  • Wosnitzer, Matthew2
  • Hruby, Greg2
  • Benson, Mitchell2
  • McKiernan, James2
  • 1 Department of Urology, Herbert Irving Cancer Center, Columbia University Medical Center, New York, New York. Electronic address: [email protected]
  • 2 Department of Urology, Herbert Irving Cancer Center, Columbia University Medical Center, New York, New York.
Type
Published Article
Journal
The Journal of urology
Publication Date
Sep 01, 2014
Volume
192
Issue
3
Pages
696–701
Identifiers
DOI: 10.1016/j.juro.2014.03.078
PMID: 24657802
Source
Medline
Keywords
License
Unknown

Abstract

With proper counseling and identification of treatment goals patients with cT0 after neoadjuvant chemotherapy for muscle invasive bladder cancer may have the option to retain the bladder with durable survival. Larger studies are needed to identify possible predictors of response on the clinical, pathological and molecular levels.

Report this publication

Statistics

Seen <100 times